Computerized Screen for Adverse Events Associated with SSRI's in Youth

青少年与 SSRI 相关不良事件的计算机筛查

基本信息

项目摘要

DESCRIPTION (provided by applicant): The recent controversy concerning the relationship between antidepressant medication and suicidal ideation and behavior has highlighted the need for better methods for standardized and systematic monitoring of adverse events associated with the use of such agents. The aim of this project is to develop better methods to systematically screen for and assess adverse events associated with the use of antidepressant medications with children and adolescents, including suicidal events and symptoms/behaviors thought to portend increased suicide risk. The methods to be developed are necessary for a planned R01 study to (1) evaluate the risks of antidepressant medications and (2) examine the impact of introducing a standardized safety monitoring procedure on clinical practice. Two methods will be developed: (1) A computerized screening instrument for adverse events experienced by children and adolescents who take SSRI's and other anti-depressant medications. The this instrument will: (a) have parent and youth versions (b) use sound technology so that the computer "reads" the questions, allowing use with those of limited reading ability, (c) yield an instant report that will indicate areas of possible concern and (d) be feasible to include in psychopharmacological research trials and busy community settings (2) A standard glossary of adverse events and materials (including videotapes) which can be used to systematically classify specific adverse events thought to be associated with treatment of depressive illness. The glossary will help improve the classification of adverse event reports The performance characteristics -- test-retest reliability, validity, feasibility, acceptability to clinicians and patients (and parents) - of the computerized AE screening instrument will be evaluated in 80 child and adolescent/parent pairs. Data from the study will be used to refine the screen and will serve as a foundation for the R01 application, which will be prepared during the second year of the project. A second long term goal of the research is to develop a user friendly, psychometrically sound assessment method that might be used in typical community settings to better monitor the safety of antidepressant medications with pediatric patients.
描述(由申请人提供):最近关于抗抑郁药物与自杀意念和行为之间关系的争议强调了需要更好的方法来标准化和系统地监测与使用此类药物相关的不良事件。该项目的目的是开发更好的方法来系统地筛查和评估与儿童和青少年使用抗抑郁药物相关的不良事件,包括自杀事件和被认为预示自杀风险增加的症状/行为。所开发的方法对于计划的R 01研究是必要的,以(1)评价抗抑郁药物的风险和(2)检查引入标准化安全性监测程序对临床实践的影响。将开发两种方法:(1)一种计算机化的筛查工具,用于筛查服用SSRI和其他抗抑郁药物的儿童和青少年所经历的不良事件。该文书将:(a)让家长版和青少年版(B)使用声音技术,以便计算机“阅读”问题,允许阅读能力有限的人使用,(c)产生一份即时报告,指出可能关注的领域,(d)可纳入精神药理学研究试验和忙碌社区环境(2)不良事件和材料的标准词汇表(包括录像带),可用于系统分类被认为与抑郁症治疗相关的特定不良事件。该词汇表将有助于改善不良事件报告的分类。将在80对儿童和青少年/父母中评价计算机化AE筛查工具的性能特征--重测信度、效度、可行性、临床医生和患者(及父母)的可接受性。该研究的数据将用于优化筛选,并将作为R 01应用程序的基础,该应用程序将在项目的第二年进行准备。该研究的第二个长期目标是开发一种用户友好的,心理测量学上合理的评估方法,可用于典型的社区环境,以更好地监测儿科患者抗抑郁药物的安全性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Prudence Winslow Fisher其他文献

Prudence Winslow Fisher的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Prudence Winslow Fisher', 18)}}的其他基金

Using multiple datasets to examine youth psychiatric diagnosis
使用多个数据集检查青少年精神病学诊断
  • 批准号:
    8268457
  • 财政年份:
    2009
  • 资助金额:
    $ 22.49万
  • 项目类别:
Using multiple datasets to examine youth psychiatric diagnosis
使用多个数据集检查青少年精神病学诊断
  • 批准号:
    7736546
  • 财政年份:
    2009
  • 资助金额:
    $ 22.49万
  • 项目类别:
Using multiple datasets to examine youth psychiatric diagnosis
使用多个数据集检查青少年精神病学诊断
  • 批准号:
    7903402
  • 财政年份:
    2009
  • 资助金额:
    $ 22.49万
  • 项目类别:
Using multiple datasets to examine youth psychiatric diagnosis
使用多个数据集检查青少年精神病学诊断
  • 批准号:
    8063907
  • 财政年份:
    2009
  • 资助金额:
    $ 22.49万
  • 项目类别:
Computerized Screen Adverse Events Associated SSRI's
电脑屏幕显示与 SSRI 相关的不良事件
  • 批准号:
    7162422
  • 财政年份:
    2006
  • 资助金额:
    $ 22.49万
  • 项目类别:

相似海外基金

Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10707830
  • 财政年份:
    2023
  • 资助金额:
    $ 22.49万
  • 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
  • 批准号:
    479728
  • 财政年份:
    2023
  • 资助金额:
    $ 22.49万
  • 项目类别:
    Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
  • 批准号:
    10884567
  • 财政年份:
    2023
  • 资助金额:
    $ 22.49万
  • 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
  • 批准号:
    10751964
  • 财政年份:
    2023
  • 资助金额:
    $ 22.49万
  • 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
  • 批准号:
    486321
  • 财政年份:
    2022
  • 资助金额:
    $ 22.49万
  • 项目类别:
    Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10676786
  • 财政年份:
    2022
  • 资助金额:
    $ 22.49万
  • 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10440970
  • 财政年份:
    2022
  • 资助金额:
    $ 22.49万
  • 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
  • 批准号:
    10642998
  • 财政年份:
    2022
  • 资助金额:
    $ 22.49万
  • 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10482465
  • 财政年份:
    2022
  • 资助金额:
    $ 22.49万
  • 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
  • 批准号:
    10191053
  • 财政年份:
    2020
  • 资助金额:
    $ 22.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了